Welcome to RiskMastery's Breakout Stocks - Stocks with breakout potential.
In this edition, we'll be looking at NASDAQ:MRKR ...
I believe this code is at a point of potential volatility.
If price can hold above $4.67 ... Bullish potential may be unlocked.
My key upside targets include:
- $6.21 (Conservative)
- $7.59 (Medium)
- $9.12 (Aggressive)
...
Hello folks
MRKR (Marker Therapeutics, Inc) still sleeping but its worth to thinking about.
Why?
MARKER THERAPEUTICS is a clinical-stage immuno-oncology c NASDAQ:MRKR ompany, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...
The 9ema is crossing the 20 ema and the MACD just crossed. I'd like to see the price break the .50 fibonacci level to enter for a long swing.
Target: 2.74, 2.99. 3.30
Bullish Flag (48%)
Pros:
Volume during post formation
Descending volume during Flag formation
Golden cross in blue
PPS above 200MA
RS above 0
R/R ratio above 3
ATR ascending
Cons:
200MA flat
250RSI below 50
PPS below 50MA
RS Flat descending
Target:
PT = 3.50$
Help how ever you can to keep this alive.
Thank you to those who have donated Coins!
Always do your own...
Greetings
Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox).
Pra Trading :
- Please care for Money Management
- Have a good psychology
- Do not be hurry to open position and do not do...
Saw this call on wallstreetbets yesterday and it looks like a very interesting call. Read more here: www.reddit.com
Summary for TLDR: Their CEO guys bought a ton of stocks recently and they are into experimental cancer drugs. So maybe there is something on the horizon. If you zoom out on the monthly it has an obscene dilution similar to VISL. Go apes go.
MRKR has been a sleeper all year. No major high-volume days and nothing really to write home about. But it managed to pull off a bigger move earlier on. Now that the gap has filled from the drop a few weeks ago & they secured funds, what will this mean for the company's next steps?
"An onslaught of Form 4s showed hand fulls of investors and insiders...
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications.
NASDAQ:MRKR
A risky yet interesting trade: Buy/Sell Zones is in the green line, but we should consider it as a pullback - the overall downtrend + bearish momentum.
I may consider Short up 0.786 Fib (where we can see another pullback) but could dip even lower.
Invalidation: closing above 1.75 on higher timeframes (12H, 1D).
Disclaimer: This article should not...
MRKR: Marker Therapeutics, Inc.
2020-04-29 16:05:00
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
MRKR
Entered MRKR at $4.01 on Friday (11/1/19) and am monitoring for a sustained trend reversal. Watching for SP to bounce off $4.10, or if that does not hold, $4.01. If it does not reverse here I think it'll consolidate between $3.83 and $4.32. A reversal would coincide with a run-up into Q3 earnings which should be sometime this month and phase 2 data in...
MRKR showing signs of life after testing a key Fibonacci level of support.
Chart:
Double bottom
CCI moved positive (inferring a nice loading zone)
MS Signal is showing "Over-Sold" conditions
Key *Support needs to hold $3.80
Key *Resistance at $4.53 then $5.29 (highlighted in green shaded area)
Disclosure: I do not own MRKR. I may buy/ sell within...
After recapturing its 200 DMA a week ago on meaningful volume, the shares of MARKER THERAPEUTICS INC - NASDAQ;MRKR have found themselves consolidating the recent move in a constructive and orderly manner as is evidenced in the Daily chart above.
With the stock now trading above all of its important moving averages 20/50/200 DMA's, the technical posture is...
